(PharmaNewsWire.Com, December 04, 2018 ) “Global Cystic Fibrosis Therapeutics Market 2018” report provides information on grasping newer technologies and recent development made in Cystic Fibrosis Therapeutics & satisfies specialized and enterprise-wide statistical needs.
This report focuses on the global Cystic Fibrosis Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cystic Fibrosis Therapeutics development in United States, Europe and China.
In 2017, the global Cystic Fibrosis Therapeutics market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025.
The key players covered in this study AbbVie Novartis F. Hoffmann-La Roche Vertex Pharmaceuticals Gilead Sciences AstraZeneca Bayer Advanced Inhalation Therapies Cyclacel Pharmaceuticals Kamada Nivalis Therapeutics Allergan Anthera Pharmaceuticals Chiesi Farmaceutici S.p.A. ProQR Therapeutics PTC Therapeutics Savara Parion Sciences Pharmaxis Vectura Group
Market segment by Type, the product can be split into Small Molecules Biologics
Market segment by Application, split into Hospitals Clinics Other
Market segment by Regions/Countries, this report covers United States Europe China Japan Southeast Asia India Central & South America
The study objectives of this report are: To analyze global Cystic Fibrosis Therapeutics status, future forecast, growth opportunity, key market and key players. To present the Cystic Fibrosis Therapeutics development in United States, Europe and China. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Cystic Fibrosis Therapeutics are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025 For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Cystic Fibrosis Therapeutics Market Size Growth Rate by Type (2013-2025) 1.4.2 Small Molecules 1.4.3 Biologics 1.5 Market by Application 1.5.1 Global Cystic Fibrosis Therapeutics Market Share by Application (2013-2025) 1.5.2 Hospitals 1.5.3 Clinics 1.5.4 Other 1.6 Study Objectives 1.7 Years Considered
2 Global Growth Trends 2.1 Cystic Fibrosis Therapeutics Market Size 2.2 Cystic Fibrosis Therapeutics Growth Trends by Regions 2.2.1 Cystic Fibrosis Therapeutics Market Size by Regions (2013-2025) 2.2.2 Cystic Fibrosis Therapeutics Market Share by Regions (2013-2018) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities
3 Market Share by Key Players 3.1 Cystic Fibrosis Therapeutics Market Size by Manufacturers 3.1.1 Global Cystic Fibrosis Therapeutics Revenue by Manufacturers (2013-2018) 3.1.2 Global Cystic Fibrosis Therapeutics Revenue Market Share by Manufacturers (2013-2018) 3.1.3 Global Cystic Fibrosis Therapeutics Market Concentration Ratio (CR5 and HHI) 3.2 Cystic Fibrosis Therapeutics Key Players Head office and Area Served 3.3 Key Players Cystic Fibrosis Therapeutics Product/Solution/Service 3.4 Date of Enter into Cystic Fibrosis Therapeutics Market 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application 4.1 Global Cystic Fibrosis Therapeutics Market Size by Type (2013-2018) 4.2 Global Cystic Fibrosis Therapeutics Market Size by Application (2013-2018)
5 United States 5.1 United States Cystic Fibrosis Therapeutics Market Size (2013-2018) 5.2 Cystic Fibrosis Therapeutics Key Players in United States 5.3 United States Cystic Fibrosis Therapeutics Market Size by Type 5.4 United States Cystic Fibrosis Therapeutics Market Size by Application
6 Europe 6.1 Europe Cystic Fibrosis Therapeutics Market Size (2013-2018) 6.2 Cystic Fibrosis Therapeutics Key Players in Europe 6.3 Europe Cystic Fibrosis Therapeutics Market Size by Type 6.4 Europe Cystic Fibrosis Therapeutics Market Size by Application
7 China 7.1 China Cystic Fibrosis Therapeutics Market Size (2013-2018) 7.2 Cystic Fibrosis Therapeutics Key Players in China 7.3 China Cystic Fibrosis Therapeutics Market Size by Type 7.4 China Cystic Fibrosis Therapeutics Market Size by Application
8 Japan 8.1 Japan Cystic Fibrosis Therapeutics Market Size (2013-2018) 8.2 Cystic Fibrosis Therapeutics Key Players in Japan 8.3 Japan Cystic Fibrosis Therapeutics Market Size by Type 8.4 Japan Cystic Fibrosis Therapeutics Market Size by Application
9 Southeast Asia 9.1 Southeast Asia Cystic Fibrosis Therapeutics Market Size (2013-2018) 9.2 Cystic Fibrosis Therapeutics Key Players in Southeast Asia 9.3 Southeast Asia Cystic Fibrosis Therapeutics Market Size by Type 9.4 Southeast Asia Cystic Fibrosis Therapeutics Market Size by Application
10 India 10.1 India Cystic Fibrosis Therapeutics Market Size (2013-2018) 10.2 Cystic Fibrosis Therapeutics Key Players in India 10.3 India Cystic Fibrosis Therapeutics Market Size by Type 10.4 India Cystic Fibrosis Therapeutics Market Size by Application
11 Central & South America 11.1 Central & South America Cystic Fibrosis Therapeutics Market Size (2013-2018) 11.2 Cystic Fibrosis Therapeutics Key Players in Central & South America 11.3 Central & South America Cystic Fibrosis Therapeutics Market Size by Type 11.4 Central & South America Cystic Fibrosis Therapeutics Market Size by Application
12 International Players Profiles 12.1 AbbVie 12.1.1 AbbVie Company Details 12.1.2 Company Description and Business Overview 12.1.3 Cystic Fibrosis Therapeutics Introduction 12.1.4 AbbVie Revenue in Cystic Fibrosis Therapeutics Business (2013-2018) 12.1.5 AbbVie Recent Development 12.2 Novartis 12.2.1 Novartis Company Details 12.2.2 Company Description and Business Overview 12.2.3 Cystic Fibrosis Therapeutics Introduction 12.2.4 Novartis Revenue in Cystic Fibrosis Therapeutics Business (2013-2018) 12.2.5 Novartis Recent Development 12.3 F. Hoffmann-La Roche 12.3.1 F. Hoffmann-La Roche Company Details 12.3.2 Company Description and Business Overview 12.3.3 Cystic Fibrosis Therapeutics Introduction 12.3.4 F. Hoffmann-La Roche Revenue in Cystic Fibrosis Therapeutics Business (2013-2018) 12.3.5 F. Hoffmann-La Roche Recent Development 12.4 Vertex Pharmaceuticals 12.4.1 Vertex Pharmaceuticals Company Details 12.4.2 Company Description and Business Overview 12.4.3 Cystic Fibrosis Therapeutics Introduction 12.4.4 Vertex Pharmaceuticals Revenue in Cystic Fibrosis Therapeutics Business (2013-2018) 12.4.5 Vertex Pharmaceuticals Recent Development 12.5 Gilead Sciences 12.5.1 Gilead Sciences Company Details 12.5.2 Company Description and Business Overview 12.5.3 Cystic Fibrosis Therapeutics Introduction 12.5.4 Gilead Sciences Revenue in Cystic Fibrosis Therapeutics Business (2013-2018) 12.5.5 Gilead Sciences Recent Development 12.6 AstraZeneca 12.6.1 AstraZeneca Company Details 12.6.2 Company Description and Business Overview 12.6.3 Cystic Fibrosis Therapeutics Introduction 12.6.4 AstraZeneca Revenue in Cystic Fibrosis Therapeutics Business (2013-2018) 12.6.5 AstraZeneca Recent Development 12.7 Bayer 12.7.1 Bayer Company Details 12.7.2 Company Description and Business Overview 12.7.3 Cystic Fibrosis Therapeutics Introduction 12.7.4 Bayer Revenue in Cystic Fibrosis Therapeutics Business (2013-2018) 12.7.5 Bayer Recent Development 12.8 Advanced Inhalation Therapies 12.8.1 Advanced Inhalation Therapies Company Details 12.8.2 Company Description and Business Overview 12.8.3 Cystic Fibrosis Therapeutics Introduction 12.8.4 Advanced Inhalation Therapies Revenue in Cystic Fibrosis Therapeutics Business (2013-2018) 12.8.5 Advanced Inhalation Therapies Recent Development 12.9 Cyclacel Pharmaceuticals 12.9.1 Cyclacel Pharmaceuticals Company Details 12.9.2 Company Description and Business Overview 12.9.3 Cystic Fibrosis Therapeutics Introduction 12.9.4 Cyclacel Pharmaceuticals Revenue in Cystic Fibrosis Therapeutics Business (2013-2018) 12.9.5 Cyclacel Pharmaceuticals Recent Development 12.10 Kamada 12.10.1 Kamada Company Details 12.10.2 Company Description and Business Overview 12.10.3 Cystic Fibrosis Therapeutics Introduction 12.10.4 Kamada Revenue in Cystic Fibrosis Therapeutics Business (2013-2018) 12.10.5 Kamada Recent Development 12.11 Nivalis Therapeutics 12.12 Allergan 12.13 Anthera Pharmaceuticals 12.14 Chiesi Farmaceutici S.p.A. 12.15 ProQR Therapeutics 12.16 PTC Therapeutics 12.17 Savara 12.18 Parion Sciences 12.19 Pharmaxis 12.20 Vectura Group
13 Market Forecast 2018-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2018-2025) 13.10 Market Size Forecast by Application (2018-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details
About Decision Market Reports Decision Market Reports is a one-stop solution, covers market research studies of all the industries, companies and regions. DMR aims at providing quality research, and insights about every market to helps our clients in taking right decisions. Our repository consists of most trending industry reports, niche areas, and leading company profiles. A comprehensive collection of reports is updated daily to offer hassle-free access to our latest updated report databases.
Contact Information: Gasper James, Decision Market Reports, 304 S Jones Blvd, Las Vegas, NV 89107, USA Call: 1-800-526-8630 (Toll-Free) Email:sales@decisionmarketreports.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: